1. Home
  2. RA vs VALN Comparison

RA vs VALN Comparison

Compare RA & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RA
  • VALN
  • Stock Information
  • Founded
  • RA 2016
  • VALN 2012
  • Country
  • RA United States
  • VALN France
  • Employees
  • RA N/A
  • VALN N/A
  • Industry
  • RA Investment Managers
  • VALN Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • RA Finance
  • VALN Health Care
  • Exchange
  • RA Nasdaq
  • VALN Nasdaq
  • Market Cap
  • RA 741.9M
  • VALN 595.2M
  • IPO Year
  • RA N/A
  • VALN 2021
  • Fundamental
  • Price
  • RA $13.43
  • VALN $7.44
  • Analyst Decision
  • RA
  • VALN Strong Buy
  • Analyst Count
  • RA 0
  • VALN 2
  • Target Price
  • RA N/A
  • VALN $17.00
  • AVG Volume (30 Days)
  • RA 280.8K
  • VALN 81.7K
  • Earning Date
  • RA 01-01-0001
  • VALN 03-20-2025
  • Dividend Yield
  • RA 14.73%
  • VALN N/A
  • EPS Growth
  • RA N/A
  • VALN N/A
  • EPS
  • RA N/A
  • VALN N/A
  • Revenue
  • RA N/A
  • VALN $176,817,979.00
  • Revenue This Year
  • RA N/A
  • VALN $22.73
  • Revenue Next Year
  • RA N/A
  • VALN $11.39
  • P/E Ratio
  • RA N/A
  • VALN N/A
  • Revenue Growth
  • RA N/A
  • VALN N/A
  • 52 Week Low
  • RA $11.89
  • VALN $3.62
  • 52 Week High
  • RA $17.32
  • VALN $9.50
  • Technical
  • Relative Strength Index (RSI)
  • RA 51.80
  • VALN 60.56
  • Support Level
  • RA $13.36
  • VALN $6.62
  • Resistance Level
  • RA $13.55
  • VALN $8.42
  • Average True Range (ATR)
  • RA 0.08
  • VALN 0.46
  • MACD
  • RA 0.00
  • VALN 0.05
  • Stochastic Oscillator
  • RA 50.00
  • VALN 69.85

About RA Brookfield Real Assets Income Fund Inc.

Brookfield Real Assets Income Fund Inc. is a diversified, closed-end management investment company. Its investment objective is to seek a high total return, through high current income and secondarily, through the growth of capital. The Fund seeks to achieve its investment objective by investing in the real asset class, which includes the following: Real Estate Securities; Infrastructure Securities; and Natural Resources Securities (collectively, Real Asset Companies and Issuers). The Firm manages separate accounts, registered funds, and opportunistic strategies for institutional and individual clients, including financial institutions, public and private pension plans, insurance companies, endowments and foundations, sovereign wealth funds, and high-net-worth investors.

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates the majority of its revenue from product sales.

Share on Social Networks: